Understanding America’s State of Mind

  • August 27, 2020
  • 1:00 PM – 2:00 PM ET
  • online

America is in the grip of a mental health crisis. One in five U.S. adults experience a mental illness event each year, but only 40% of them receive treatment. Social stigma and inadequate access to care create barriers to effective treatment, and people with these conditions are at higher risk for a wide range of diseases leading to higher costs of care. In fact, people who have both a mental health condition and a chronic disease have two to three times higher health care costs than those with only a chronic disease.

Mental health conditions are the costliest health conditions in the U.S., and the rising prevalence of these conditions is negatively impacting your members and their families. Unmanaged mental health conditions don’t just lead to missed work days and lost productivity but are also reflected in higher employee turnover, cost of hiring new employees and repeated job training. They also cost the U.S. health care system more than $200 billion annually and more than $193 billion in lost earnings per year.

Join our expert panel as they discuss how increased awareness and open conversation on mental health conditions can enable a greater level of support that will maximize clinical outcomes and promote mental wellness, ultimately driving down the total cost of care.

Attendees will learn:

  • The latest emerging trends across the industry as it relates to mental health conditions and treatment
  • The impact of mental health conditions among members and payers
  • How to lower the total cost of care, deliver increased productivity and ensure members get the support they need for a healthier and happier life


Kelcey Blair, PharmD
Vice President, Clinical Solutions
Express Scripts

Kelcey Blair has more than 16 years of experience in pharmacy working on the retail, specialty and PBM sides. She joined Express Scripts over 10 years ago and is currently Vice President of Clinical Solutions, where she and her team are responsible for a variety of clinical solutions including the new inMynd behavioral health solution, utilization management programs and award-winning advanced opioid management program. She is a registered pharmacist and holds a Bachelor of Science in Pharmacy degree from St. Louis College of Pharmacy and a Doctor of Pharmacy degree from Massachusetts College of Pharmacy and Health Sciences, Boston.

Zac Goodman, MD
Director, Clinical Innovation
Express Scripts

Zac Goodman is a physician and works within the Express Scripts Lab in St. Louis developing innovative solutions for patients and providers. Notably, Dr. Goodman is part of the team that launched the Express Scripts Digital Health Formulary. He received his Doctor of Medicine degree from The Ohio State University College of Medicine.

Rochelle Henderson, PhD
Vice President of Health Services Research
Express Scripts

Rochelle Henderson is Vice President of Health Services Research for Express Scripts. In this capacity, she supervises a team of Ph. D. health policy researchers and works with schools of pharmacy and medical schools in the greater St. Louis area. She serves on a number of health-related research teams with institutions across the St. Louis region: Washington University School of Medicine with Barnes Hospital, the Veteran’s Administration Regional Hospital and the School of Nursing from Southern Illinois University at Edwardsville (SIUE). She has 20 years of experience in pharmacoepidemiologic and pharmacoeconomic research. Dr. Henderson also has extensive publishing credits including numerous peer-reviewed articles in the American Journal of Managed Care, Journal of Managed Care Pharmacy, Annals of Pharmocotherapy, Clinical Therapeutics and other prestigious journals. Dr. Henderson received her Doctorate from the University of Missouri – St. Louis.